Abstract:Copper trafficking proteins have been implicated in the cellular response to platinum anticancer drugs. We investigated the reaction of the chaperone Atox1 with an activated form of oxaliplatin, the third platinum drug to reach worldwide approval. Unlike cisplatin, which contains monodentate ammines, oxaliplatin contains chelated 1,2-diaminocyclohexane (DACH), which is more resistant to displacement by nucleophiles. In solution, one or two {Pt(DACH)(2+)} moieties bind to the conserved CXXC metal-binding motif of Atox1; in the latter case the two sulfur atoms likely bridging the two platinum units. At longer reaction times, a dimeric species is formed whose composition, Atox12·Pt(2+)2, indicates complete loss of the diamine ligands. Such a dimerization process is accompanied by partial unfolding of the protein. Crystallization experiments aiming at the characterization of the monomeric species have afforded, instead, a dimeric species resembling that already obtained by Boal and Rosenzweig in a similar reaction performed with cisplatin. However, while in the latter case there was only one Pt-binding site (0.4 occupancy) made of four sulfur atoms of the CXXC motifs of the two Atox1 chains in a tetrahedral arrangement, we found, in addition, a secondary Pt-binding site involving Cys41 of the B chain (0.25 occupancy). Moreover, both platinum atoms have lost their diamines. Thus, there appears to be little relationship between what is observed in solution and what is formed in the solid state. Since full occupancy of the tetrahedral cavity is a common feature of all Atox1 dimeric structures obtained with other metal ions (Cu(+), Cd(2+), and Hg(2+)), we propose that in the case of platinum, where the occupancy is only 0.4, the remaining cavities are occupied by Cu(+) ions. Experimental evidence is reported in support of the latter hypothesis. Our proposal represents a meeting point between the initial proposal of Boal and Rosenzweig (0.4 Pt occupancy) and the reinterpretation of the original crystallographic data put forward by Shabalin et al. (1 Cu occupancy), and could apply to other cases.

Targeted Binding of a Platinum(ii)–methionine Complex to the Disulfide Linkage of a Nonapeptide Oxytocin

Compositions and Conformations of Several Transition Metal Complexes with a Nonapeptide Hormone Oxytocin †

Interactions of Platinum(ii) Complexes with Sulfur‐containing Peptides Studied by Electrospray Ionization Mass Spectrometry and Tandem Mass Spectrometry

Novel polynuclear platinum adducts detected during the reactions of [Pt(Met-S,N)Cl2] with γ-glutathione and l-cysteine

Oxaliplatin Binding to Human Copper Chaperone Atox1 and Protein Dimerization

Mass Spectrometry Assisted Assignments of Binding and Cleavage Sites of Copper(ii) and Platinum(ii) Complexes Towards Oxidized Insulin B Chain.

Disulfide Bond Cleavage Induced by a Platinum(II) Methionine Complex

Fast Displacement of S,N-chelated L-Methionine in Platinum(ii) Complexes by Biological Thiols

From Preassociation to Chelation: A Survey of Cisplatin Interaction with Methionine at Molecular Level by IR Ion Spectroscopy and Computations

A Comparative Study on Interactions of Cisplatin and Ruthenium Arene Anticancer Complexes with Metallothionein Using MALDI-TOF-MS

Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1

Synthesis, Reactivity Studies and Cytotoxicity of Two Iodidoplatinum(II) Complexes. Does Photoactivation Work?

Chelate-ring-opened Adducts of [Pt(en)(me-Mal-o,o′)] (en = Ethane-1,2-diamine, Me-Mal = 2-Methylmalonate) with Methionine Derivatives: Relevance to the Biological Activity of Platinum Anticancer Agents

Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes.

Noncovalent Interactions Between a Trinuclear Monofunctional Platinum Complex and Human Serum Albumin.

Simultaneous mass spectrometry analysis of cisplatin with oligonucleotide-peptide mixtures: implications for the mechanism of action

Determinants for simultaneous binding of copper and platinum to human chaperone Atox1: hitchhiking not hijacking

Picoplatin binding to proteins: X-ray structures and mass spectrometry data on the adducts with lysozyme and ribonuclease A

Reactions of Platinum II Complexes with Sulfur- and Nitrogen-Containing Biomolecules: Selective Intermolecular Migration of the Thioether-Bound Platinum II Complex to the N7 Nitrogen Atom of Guanosine-5’-Monophosphate

Synthesis and anticancer mechanisms of four novel platinum(II) 4′-substituted-2,2′:6′,2′′-terpyridine complexes

Fast Cleavage of a Diselenide Induced by a Platinum(ii)-Methionine Complex and Its Biological Implications.